HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dora Pinto Selected Research

Zoonoses

1/2022Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
12/2021Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
4/2021Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
1/2021Broad sarbecovirus neutralization by a human monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dora Pinto Research Topics

Disease

5COVID-19
09/2021 - 11/2020
4Zoonoses
01/2022 - 01/2021
3Infections
06/2022 - 01/2021
1Breakthrough Infections
06/2022
1Communicable Diseases (Infectious Diseases)
06/2010
1Neoplasms (Cancer)
07/2007

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
06/2022 - 06/2010
4Monoclonal AntibodiesIBA
01/2022 - 01/2021
3Glycoproteins (Glycoprotein)IBA
09/2021 - 01/2021
3Neutralizing AntibodiesIBA
01/2021 - 11/2020
2EpitopesIBA
01/2022 - 12/2021
2Broadly Neutralizing AntibodiesIBA
04/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2021
1AntibodiesIBA
06/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
06/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
06/2022
1Messenger RNA (mRNA)IBA
04/2021
1S2X259IBA
01/2021

Therapy/Procedure

1Immunotherapy
07/2007